Company / Operating Cash Flow per Share
Aurinia Pharmaceuticals Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.96
FY2025
5-year range
-$0.57 / $0.96
FY2021-FY2025
Trend
+212.0%
vs FY2024
Sector context
#55 of 212
Health Care
What the data says
Operating Cash Flow per Share changed +212% YoY in FY2025, a notable deviation from the 7-year average annual change of +72%.
Based on SEC 10-K filings.
0.96 in FY2025.
Improved from $-0.24 to $0.96 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#55 of 212 in Health CareTop 26% of 212This company $0.96 Sector average $5.28
▼
-81.8% below sector average
Key checks
Key Insights
- Aurinia Pharmaceuticals Inc.'s operating cash flow per share has grown for 5 consecutive years.
- In FY2025, operating cash flow per share increased 212.0% year-over-year.
- Ranks #55 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.96 | +212.0% |
| FY2024 | $0.31 | +230.6% |
| FY2023 | -$0.24 | +57.1% |
| FY2022 | -$0.55 | +3.1% |
| FY2021 | -$0.57 | +30.4% |
| FY2020 | -$0.82 | -19.5% |
| FY2019 | -$0.68 | -12.3% |
| FY2018 | -$0.61 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026